Cargando…

Prolonged PR Interval and Outcome in Cardiac Resynchronization Therapy

Detalles Bibliográficos
Autores principales:	Kewcharoen, Jakrin, Kanitsoraphan, Chanavuth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684180/ https://www.ncbi.nlm.nih.gov/pubmed/31411299 http://dx.doi.org/10.5935/abc.20190101

Ejemplares similares

Simultaneous Bilateral Primary Spontaneous Pneumothorax: A Case Report and a Review of the Literature
por: Kewcharoen, Jakrin, et al.
Publicado: (2019)

Female Gender Is Associated with an Increased Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure with Reduced Ejection Fraction
por: Kewcharoen, Jakrin, et al.
Publicado: (2022)

Postimplantation pocket hematoma increases risk of cardiac implantable electronic device infection: A meta‐analysis
por: Kewcharoen, Jakrin, et al.
Publicado: (2021)

Baseline atrial fibrillation is a risk factor for erectile dysfunction: Systemic review and meta-analysis
por: Prasitlumkum, Narut, et al.
Publicado: (2019)

Baseline Prolonged PR Interval and Outcome of Cardiac Resynchronization Therapy: A Systematic Review and Meta-analysis
por: Rattanawong, Pattara, et al.
Publicado: (2018)

Cognitive impairment associated with increased mortality rate in patients with heart failure: A systematic review and meta-analysis
por: Kewcharoen, Jakrin, et al.
Publicado: (2019)

Cognitive impairment and 30-day rehospitalization rate in patients with acute heart failure: A systematic review and meta-analysis
por: Kewcharoen, Jakrin, et al.
Publicado: (2019)

The efficacy of posterior wall isolation in atrial fibrillation ablation: A systematic review and meta‐analysis of randomized controlled trials
por: Kanitsoraphan, Chanavuth, et al.
Publicado: (2022)

Type of syncope and outcome in Brugada syndrome: A systematic review and meta‐analysis
por: Rattanawong, Pattara, et al.
Publicado: (2023)

Can We Consider PR Interval to Screen Patients for Cardiac Resynchronization Therapy?
por: Martinelli Filho, Martino
Publicado: (2018)

Wide QRS complex and the risk of major arrhythmic events in Brugada syndrome patients: A systematic review and meta‐analysis
por: Rattanawong, Pattara, et al.
Publicado: (2019)

Does the Age of Sudden Cardiac Death in Family Members Matter in Brugada Syndrome?
por: Rattanawong, Pattara, et al.
Publicado: (2021)

Cardiac resynchronization therapy improved the clinical outcomes in pacemaker patients upgraded to biventricular device
por: Jin, Han, et al.
Publicado: (2017)

QRS narrowing and prediction of res-ponse to cardiac resynchronization therapy
por: Uçar, Fatih Mehmet
Publicado: (2018)

Analysis of tricuspid regurgitation improvement following cardiac resynchronization therapy
por: Ahmad, Syed Yousaf, et al.
Publicado: (2023)

Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy
por: Imamura, Teruhiko
Publicado: (2020)

Vectorcardiography for Optimization of Stimulation Intervals in Cardiac Resynchronization Therapy
por: van Deursen, Caroline J. M., et al.
Publicado: (2015)

Analysis of tricuspid regurgitation improvement following cardiac resynchronization therapy—Authors’ reply
por: Stassen, Jan, et al.
Publicado: (2023)

Ketamine-induced QTc interval prolongation
por: Singh, Tejinder S. Swaran, et al.
Publicado: (2017)

Marked PR interval variability in a patient with Brugada syndrome
por: Martins de Carvalho, Miguel, et al.
Publicado: (2023)

Does subclinical atrial fibrillation independently predict adverse outcomes in patients with heart failure and cardiac resynchronization therapy defibrillator
por: Chen, Jie, et al.
Publicado: (2021)

Cardiac Resynchronization Therapy for Transthyretin Cardiac Amyloidosis
por: Donnellan, Eoin, et al.
Publicado: (2020)

QTc interval prolongation, COVID-19 and chloroquine
por: Wiwanitkit, V.
Publicado: (2020)

To the Editor – Cardiac resynchronization therapy in coronary sinus atresia delivered using leadless endocardial pacing
por: van Gelder, Berry M., et al.
Publicado: (2017)

Progressively Prolonged PR Interval and Aortic Abscess
por: Ali, Murtaza, et al.
Publicado: (2023)

Reply to Letter to the Editor: “Diabetes Mellitus as a Protective Factor in Takotsubo Cardiomyopathy”
por: Thangjui, Sittinun, et al.
Publicado: (2023)

Epicardial Lead Placement for Cardiac Resynchronization Therapy in Dilated Cardiomyopathy Patient: Fine Tuning Anaesthetic Challenges
por: Damodaran, Srinath, et al.
Publicado: (2020)

Resynchronization therapy in an adolescent with pacemaker-related ventricular dysfunction
por: Cevik, Ayhan, et al.
Publicado: (2012)

Effect of dynamic atrioventricular and interventricular delay optimization for cardiac resynchronization therapy on cardiac function and neuroendocrine factors in patients with congestive heart failure
por: Wu, Haoyu, et al.
Publicado: (2021)

Therapeutic implications of statins in heart failure with reduced ejection fraction and heart failure with preserved ejection fraction: a review of current literature
por: Techorueangwiwat, Chol, et al.
Publicado: (2021)

Psychotropic Drugs and Prolonged QTc Interval: Does it Really that Matter?
por: Naguy, Ahmed
Publicado: (2016)

Epicardial echocardiography for left ventricular epicardial lead placement during cardiac resynchronization
por: Palamattam, Don Jose, et al.
Publicado: (2021)

Does pulmonary vein isolation prolong QT-interval?— Authors’ reply
por: Hermans, Ben J M, et al.
Publicado: (2021)

Simultaneous two-sided endocarditis: cardiac resynchronization leads and left atrial appendage occluder
por: von Roeder, Maximilian, et al.
Publicado: (2020)

Atrioventricular dromotropathy: an important substrate for complete resynchronization therapy—Authors’ reply
por: Salden, Floor C W M, et al.
Publicado: (2022)

An Issue Waiting to be Clarified: Effects of the QT Prolonging Drugs on Tp-e Interval
por: Yiginer, Omer, et al.
Publicado: (2015)

Reply to the Editor – Regarding Cardiac Resynchronization Therapy in Coronary Sinus Atresia Delivered Using Leadless Endocardial Pacing
Publicado: (2017)

Upgrade of cardiac resynchronization therapy by utilizing additional His-bundle pacing in a patient with lamin A/C cardiomyopathy: an autopsy case report
por: Baba, Masako, et al.
Publicado: (2021)

Defining the Pathways Underlying the Prolonged PR Interval in Atrioventricular Conduction Disease
por: Curran, Jerry, et al.
Publicado: (2012)

Inadvertent QRS prolongation by an optimization device-based algorithm in patients with cardiac resynchronization therapy
por: Sedláček, Kamil, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vlvc898pjjsq15lvqlmb652cgj